Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Cardiac Biomarkers Market to reach USD 47.75 billion by the end of 2030.

Global Cardiac Biomarkers Market Size Study & Forecast, by Type (Troponin, CK-MB, Myoglobin, BNP and NT-proBNP, Others), by Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others), by End use (Laboratory Testing, Point of Care Testing), and Regional Analysis, 2023-2030

Product Code: HLSMD-87749489
Publish Date: 20-12-2023
Page: 200

Global Cardiac Biomarkers Market is valued at approximately USD 16.05 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 14.6% over the forecast period 2023-2030. Cardiac biomarkers are molecules released into the bloodstream in response to heart damage or stress. The assessment of these biomarkers is a valuable tool in the diagnosis of conditions such as Acute Coronary Syndrome (ACS) and cardiac ischemia, both of which are characterized by inadequate blood supply to the heart. Additionally, tests for cardiac biomarkers serve to evaluate an individual’s risk of developing these conditions and are instrumental in monitoring and managing individuals with suspected ACS and cardiac ischemia. The increasing demand for rapid diagnostic tests, the rise in initiatives to promote heart health, and regular screening for CVDs, along with the increasing aging population are the key factors that are fueling the demand for cardiac biomarkers across the globe.

The global prevalence of CVDs, including heart attacks and heart failure, is increasing, driving the demand for cardiac biomarker tests to aid in diagnosis and monitoring. According to the World Health Organization (WHO), it was estimated that Cardiovascular Diseases (CVDs) are recorded as the leading cause of death around the world, which takes an estimated 17.9 million lives annually. Additionally, heart attacks and strokes account for 85% of these cardiovascular disease deaths. In addition, according to an article that was published in the Cureus Journal of Medical Science in July 2020, Ischemic Heart Disease (IHD) is a significant cause of death globally. Around 126 million people worldwide (1,655 per 100,000), or roughly 1.72% of the world’s population, suffer from ischemic heart disease. It is anticipated that more than 1,845 cases of ischemic heart disease per 100,000 people worldwide by 2030. Consequentially, the rise in incidences of CVDs are propelling the growth of the Cardiac Biomarkers Market during the estimated period. Moreover, the surge in demand for Point-of-Care (POC) cardiac diagnostics, as well as the growing demand for rapid diagnostic tests present various lucrative opportunities over the forecast years. However, the complexities associated with cardiac biomarker tests and the stringent regulatory frameworks are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cardiac Biomarkers Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of a well-established healthcare system and the widespread adoption of cardiac biomarkers as a diagnostic and predictive tool for various medical conditions. The increasing elderly population, often in need of biomarker testing to detect conditions such as acute myocardial infarction, is a driving force behind the demand for these testing products. Furthermore, the presence of key industry players such as Quidel Corporation and Danaher Corporation in the region is an additional contributing factor to the market’s growth. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increasing accessibility to advanced cardiac tests, ongoing modernization efforts, and rising disposable incomes are significant contributing factors. Moreover, the escalating prevalence of cardiovascular diseases (CVDs) in this region has led to a heightened need for enhanced diagnostic tools. Government funding for targeted disease research and increased healthcare spending are also playing crucial roles. In comparison to other developing nations, India stands out with a higher incidence of CVDs. This substantial disease burden is anticipated to fuel the demand for cardiac biomarker diagnostics, as they play a pivotal role in enabling the diagnosis, assessment, and treatment of CVDs.

Major market players included in this report are:
Abbott
Quidel Corporation
Siemens Healthcare GmbH
F. Hoffmann-La Roche Ltd.
Danaher Corporation
BIOMÉRIEUX
Bio-Rad Laboratories, Inc.
Randox Laboratories Ltd.
Creative Diagnostics
Life Diagnostics, Inc.

Recent Developments in the Market:
Ø In November 2022, OMRON Healthcare and CardioSignal announced the company’s partnership agreement to develop early cardiovascular disease detection technology for cardiac health management. This partnership presents digital cardiac biomarkers that potentially save lives.
Ø In April 2021, Roche announced a series of five new planned uses for two important cardiac biomarkers (cTnT-hs) using the Elecsys technology, which has the very sensitive cardiac troponin T and NT-proBNP. This helps in improving risk detection and diagnosis and enables the company to make additional revenues from its current product line.

Global Cardiac Biomarkers Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Type, Application, End use, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Troponin
CK-MB
Myoglobin
BNP and NT-proBNP
Others

By Application:
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others

By End use:
Laboratory Testing
Point of Care Testing

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Cardiac Biomarkers Market, by Region, 2020-2030 (USD Billion)
1.2.2. Cardiac Biomarkers Market, by Type, 2020-2030 (USD Billion)
1.2.3. Cardiac Biomarkers Market, by Application, 2020-2030 (USD Billion)
1.2.4. Cardiac Biomarkers Market, by End use, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cardiac Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cardiac Biomarkers Market Dynamics
3.1. Cardiac Biomarkers Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for rapid diagnostic tests
3.1.1.2. Rise in incidences of cardiovascular diseases (CVDs)
3.1.2. Market Challenges
3.1.2.1. Complexities associated with cardiac biomarkers tests
3.1.2.2. Stringent regulatory frameworks
3.1.3. Market Opportunities
3.1.3.1. Surge in demand for Point-of-Care (POC) cardiac diagnostics
3.1.3.2. Growing demand for rapid diagnostic tests
Chapter 4. Global Cardiac Biomarkers Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cardiac Biomarkers Market, by Type
5.1. Market Snapshot
5.2. Global Cardiac Biomarkers Market by Type, Performance – Potential Analysis
5.3. Global Cardiac Biomarkers Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Cardiac Biomarkers Market, Sub Segment Analysis
5.4.1. Troponin
5.4.2. CK-MB
5.4.3. Myoglobin
5.4.4. BNP and NT-proBNP
5.4.5. Others
Chapter 6. Global Cardiac Biomarkers Market, by Application
6.1. Market Snapshot
6.2. Global Cardiac Biomarkers Market by Application, Performance – Potential Analysis
6.3. Global Cardiac Biomarkers Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Cardiac Biomarkers Market, Sub Segment Analysis
6.4.1. Acute Coronary Syndrome
6.4.2. Myocardial Infarction
6.4.3. Congestive Heart Failure
6.4.4. Others
Chapter 7. Global Cardiac Biomarkers Market, by End use
7.1. Market Snapshot
7.2. Global Cardiac Biomarkers Market by End use, Performance – Potential Analysis
7.3. Global Cardiac Biomarkers Market Estimates & Forecasts by End use 2020-2030 (USD Billion)
7.4. Cardiac Biomarkers Market, Sub Segment Analysis
7.4.1. Laboratory Testing
7.4.2. Point of Care Testing
Chapter 8. Global Cardiac Biomarkers Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Cardiac Biomarkers Market, Regional Market Snapshot
8.4. North America Cardiac Biomarkers Market
8.4.1. U.S. Cardiac Biomarkers Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End use breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Cardiac Biomarkers Market
8.5. Europe Cardiac Biomarkers Market Snapshot
8.5.1. U.K. Cardiac Biomarkers Market
8.5.2. Germany Cardiac Biomarkers Market
8.5.3. France Cardiac Biomarkers Market
8.5.4. Spain Cardiac Biomarkers Market
8.5.5. Italy Cardiac Biomarkers Market
8.5.6. Rest of Europe Cardiac Biomarkers Market
8.6. Asia-Pacific Cardiac Biomarkers Market Snapshot
8.6.1. China Cardiac Biomarkers Market
8.6.2. India Cardiac Biomarkers Market
8.6.3. Japan Cardiac Biomarkers Market
8.6.4. Australia Cardiac Biomarkers Market
8.6.5. South Korea Cardiac Biomarkers Market
8.6.6. Rest of Asia Pacific Cardiac Biomarkers Market
8.7. Latin America Cardiac Biomarkers Market Snapshot
8.7.1. Brazil Cardiac Biomarkers Market
8.7.2. Mexico Cardiac Biomarkers Market
8.8. Middle East & Africa Cardiac Biomarkers Market
8.8.1. Saudi Arabia Cardiac Biomarkers Market
8.8.2. South Africa Cardiac Biomarkers Market
8.8.3. Rest of Middle East & Africa Cardiac Biomarkers Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abbott
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Quidel Corporation
9.3.3. Siemens Healthcare GmbH
9.3.4. F. Hoffmann-La Roche Ltd.
9.3.5. Danaher Corporation
9.3.6. BIOMÉRIEUX
9.3.7. Bio-Rad Laboratories, Inc.
9.3.8. Randox Laboratories Ltd.
9.3.9. Creative Diagnostics
9.3.10. Life Diagnostics, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now